Ovarian cancer : state of the art and future directions in translational research / George Coukos, Andrew Berchuck, Robert Ozols, editors.

• Potential and limitations in early diagnosis of ovarian cancer -- SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other -- Classification of ovarian cancer : a genommic analysis -- Epigenetic markers of ovarian cancer -- Role of genetic polymorphisms in ovarian cancer susceptibility : development of an international ovarian cancer association consortium -- MicroRNA in human cancer : one step forward in diagnosis and treatment -- Ovarian carcinogenesis : an alternative hypothesis -- BRCA1-induced ovarian oncogenesis -- Role of p53 and Rb in ovarian cancer -- Ovulatory factor in ovarian carcinogenesis -- Gynecologic Oncology Group (GOG-USA) trials in ovarian cancer -- Intraperitoneal chemotherapy for ovarian cancer -- Ovarian cancer : can we reverse drug resistance? -- Syngeneic mouse model of epithelial ovarian cancer : effects of nanoparticulate paclitaxel, Nanotax® -- Individualized molecular medicine : linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients -- Defective apoptosis underlies chemoresistance in ovarian cancer -- Nanoparticle delivery of suicide DNA for epithelial ovarian cancer therapy -- Biological therapy with oncolytic herpesvirus -- Cancer immunotherapy : perspectives and prospects -- Regulatory T cells : a new frontier in cancer immunotherapy -- Inhibitory B7 family members in human ovarian carcinoma -- Role of vascular leukocytes in ovarian cancer neovascularization -- Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy. 

Ämnesord

Ovarian Neoplasms  (MeSH)

Ovarian Neoplasms  -- diagnosis (MeSH)

Ovarian Neoplasms  -- therapy (MeSH)

Klassifikation

W1 (NLM)

WP 322 (NLM)